VolitionRX Ltd VNRX 价格预测与展望

Q: VNRX 的斐波那契回调水平是多少？

VolitionRX Ltd 的斐波那契回调水平是 高于0%水平。

Q: VolitionRX Ltd 的 RSI 是多少？

VolitionRX Ltd 的 RSI 目前为 26.88，表明处于 超卖 状态



预测

VNRX 股票价格预测

VolitionRX Ltd

$2.78

2.05%

$0.05

收盘价：Apr 28, 16:00:00 GMT-4

7.91%

$0.22

盘前：Apr 29, 06:17:01 GMT-4

概述预测财报股息财务数据

关键数据

前收盘价

$2.72

开盘价

$2.57

当日区间

$2.51 - $3

52周范围

$0.15 - $3

交易量

377.5K

平均成交量

8.4M

股息收益率

每股收益（TTM）

-0.22

市值

$475.4M

什么是 VNRX？

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Henderson, Nevada and currently employs 85 full-time employees. The company went IPO on 2015-02-06. The firm is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

功能特性

Markets

News

使用条款隐私政策

According to analyst forecasts, we anticipate notable price fluctuations for VNRX in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $1.73. The lowest target is $1.01 and the highest is $3.15. Empower your investment choices with our cutting-edge, data-driven analysis!

VNRX 股价预测摘要

VNRX的顶级分析师评级

基于 12 位分析师对 VNRX 的股票评级，更新于 Feb 01, 2026

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for VNRX. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: VNRX is a Buy candidate.

VNRX stock price ended at $2.78 on 星期二, after rising 2.21%

On the latest trading day Apr 28, 2026, the stock price of VNRX rose by 2.21%, climbing from $2.57 to $2.78. During the session, the stock saw a volatility of 12.10%, with prices oscillating between a daily low of $2.48 and a high of $2.78. Notably, trading volume dropped by 313.3K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 411.4K shares were traded, equating to a market value of approximately $440.5M.

VNRX 技术面信号

技术面信号摘要

买入信号 2

中性信号 0

卖出信号 5

Strong Sell

Sell

Neutral

Buy

Strong Buy

VNRX目前显示2个买入信号和5个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为2.21%。总体而言，技术指标显示中期前景为Sell。

VNRX 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 VNRX 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 VNRX？



根据技术分析，VolitionRX Ltd 的综合信号为 Sell。VolitionRX Ltd 有 2 个买入信号，0 个中性信号和 5 个卖出信号。

VNRX 的斐波那契回调水平是多少？



VolitionRX Ltd 的斐波那契回调水平是高于0%水平。

VolitionRX Ltd 的 RSI 是多少？



VolitionRX Ltd 的 RSI 目前为 26.88，表明处于超卖状态

VolitionRX Ltd 接下来 12 个月的价格是多少？



VolitionRX Ltd VNRX 接下来 12 个月的价格预计为 $1.73。

VolitionRX Ltd 预计会涨到多高？



据华尔街分析师称，VolitionRX Ltd 预计将达到 $3.15 的高预测值。

VolitionRX Ltd (VNRX) 股票价格预测

VNRX 股价走势图